Skip to content
Clinical Trials – home
Therapeutic area

Eye disorders – page 30

  • 368 clinical trials
  • 123 recruiting
  • 134 conditions
  • 27 countries

Conditions in this area

134 conditions with trials, the busiest first

Clinical trials in Eye disorders

368 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

368 clinical trials

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Linsitinib
  • Sponsor:Sling Therapeutics Inc.
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Ripasudil
  • Sponsor:Kowa Research Institute Inc.
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Oxular IE Limited
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Bayer AG

Giant cell arteritis

Not recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Tocilizumab
  • Sponsor:Centre Hospitalier Universitaire De Dijon
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Vaestra Goetalandsregionen
Registered drug
Countries:SwedenSweden
  • Participants:0–17 years
  • Substances:Dexamethasone Phosphate
  • Sponsor:Vaestra Goetalandsregionen

Diabetic retinopathy

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bi 764524
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Avacincaptad Pegol
  • Sponsor:Astellas Pharma Global Development Inc.
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Faricimab
  • Sponsor:Medical University Of Graz

Dry eye

Not recruiting
Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Hypromellose
  • Sponsor:Hospital Clinico San Carlos
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Bilastine
  • Sponsor:Inmunotek S.L.

Substances studied in this area

The therapies tested most often in Eye disorders trials.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.